A1c Discordance in Diabetes Patients

Endocrine Research Society

Status

Suspended

Conditions

Diabetes Mellitus

Treatments

Other: Fast Glycator

Other: Control

Study type

Interventional

Funder types

Other

Identifiers

NCT01213277

A1c Discordance

Details and patient eligibility

About

HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.

Enrollment

25 estimated patients

Sex

All

Ages

25 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient with diabetes
Patients who test their sugar levels at least 3 times daily
Recorded diary of sugar levels for the past month
Willingness to have blood drawn
Willingness to allow their blood sugar diary to be photocopied
Estimated average glucose as derived from A1c is ≥ 4 mmol from measured glucose from self-monitoring blood glucose testing

Exclusion criteria

Patient with medical conditions that may affect their study participation or results will be excluded.
Patients who are anemic
Renal insufficient with a serum creatinine level > 200 μmol/L